| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | killer cell lectin like receptor K1 | ||||
| GTO ID | GTC3170 |
| Trial ID | NCT05528341 |
| Disease | Solid Tumor |
| Altered gene | NKG2D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | NKG2D-CAR-NK92 cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical Investigation of NKG2D-CAR-NK92 Chimeric Antigen Receptor Modified NK92 Cells in the Treatment of Relapsed/Refractory Solid Tumors |
| Year | 2023 |
| Country | China |
| Company sponsor | Xinxiang medical university |
| Other ID(s) | CNK-102 |
| Cohort 1 | |||||||||
|
|||||||||